Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Gene ; 540(1): 62-7, 2014 Apr 25.
Article in English | MEDLINE | ID: mdl-24560583

ABSTRACT

NADPH oxidase 4 (NOX4) is a member of the NADPH oxidase gene family that regulates cellular differentiation, innate immunity and tissue fibrosis. Transforming growth factor-ß (TGF-ß1) is known to induce expression of NOX4 mRNA in mesenchymal cells. However, the mechanisms of transcriptional regulation of NOX4 are not well understood. In this study, we examined the transcriptional regulation of NOX4 in human lung fibroblasts by TGF-ß1. Five promoter-reporter constructs containing DNA fragments of 0.74kb, 1.35kb, 1.84kb, 3.97kb and 4.76kb upstream from the transcriptional start site (TSS) of the human NOX4 gene were generated and their relative responsiveness to TGF-ß1 analyzed. TGF-ß1-induced NOX4 gene promoter activation requires a region between -3.97kb and -4.76kb. Bioinformatics analysis revealed a 15bp AP-1/Smad binding element in this region. Mutation or deletion of either the AP-1 or the Smad element attenuated TGF-ß1 responsiveness of the -4.76kb NOX4 promoter. Furthermore, insertion of this AP-1/Smad box conferred TGF-ß1 inducibility to the non-responsive -3.97kb NOX4 promoter construct. Chromatin immunoprecipitation analysis indicated that phospho-Smad3 and cJun associate with this element in a TGF-ß1-inducible manner. These results demonstrate that the AP-1/Smad box located between 3.97kb and 4.76kb upstream of the TSS site of the NOX4 promoter is essential for NOX4 gene transcription induced by TGF-ß1 in human lung fibroblasts. Our study provides insights into the molecular mechanisms of NOX4 gene expression, informing novel therapeutic approaches to interfere with upregulation of NOX4 in diseases characterized by activation of the TGF-ß1/NOX4 pathway.


Subject(s)
NADPH Oxidases/genetics , Smad3 Protein/metabolism , Transcription Factor AP-1/metabolism , Transcriptional Activation , Transforming Growth Factor beta1/physiology , Base Sequence , Binding Sites , Cell Line , Gene Expression , Humans , NADPH Oxidase 4 , NADPH Oxidases/metabolism , Promoter Regions, Genetic , Protein Binding , Proto-Oncogene Proteins c-jun/metabolism , RNA Stability
2.
J Biol Chem ; 285(22): 16476-86, 2010 May 28.
Article in English | MEDLINE | ID: mdl-20351094

ABSTRACT

HO-1 (heme oxygenase-1) is an inducible microsomal enzyme that catalyzes the degradation of pro-oxidant heme. The goal of this study was to characterize a minimal enhancer region within the human HO-1 gene and delineate its role in modulating HO-1 expression by participation with its promoter elements in renal epithelial cells. Deletion analysis and site-directed mutagenesis identified a 220-bp minimal enhancer in intron 1 of the HO-1 gene, which regulates hemin-mediated HO-1 gene expression. Small interfering RNA, decoy oligonucleotides, site-directed mutagenesis, and chromatin immunoprecipitation assays confirmed the functional interaction of Sp1 with a consensus binding sequence within the 220-bp region. Mutations of regulatory elements within the -4.5 kb promoter region (a cyclic AMP response and a downstream NF-E2/AP-1 element, both located at -4.0 kb, and/or an E-box sequence located at -44 bp) resulted in the loss of enhancer activity. A chromosome conformation capture assay performed in human renal epithelial (HK-2) cells demonstrated hemin-inducible chromatin looping between the intronic enhancer and the -4.0 kb promoter region in a time-dependent manner. Restriction digestion with ApaLI (which cleaves the 220-bp enhancer) led to a loss of stimulus-dependent chromatin looping. Sp1 small interfering RNA and mithramycin A, a Sp1 binding site inhibitor, resulted in loss of the loop formation between the intronic enhancer and the distal HO-1 promoter by the chromosome conformation capture assay. These results provide novel insight into the complex molecular interactions that underlie human HO-1 regulation in renal epithelial cells.


Subject(s)
Chromatin/chemistry , Gene Expression Regulation, Enzymologic , Heme Oxygenase-1/biosynthesis , Kidney/enzymology , Sp1 Transcription Factor/physiology , Apoptosis , Cell Line , Chromatin Immunoprecipitation , Enhancer Elements, Genetic , Hemin/chemistry , Humans , Mutagenesis , Plasmids/metabolism , Promoter Regions, Genetic , RNA, Small Interfering/metabolism , Transfection
3.
Biochem J ; 422(2): 353-61, 2009 Aug 13.
Article in English | MEDLINE | ID: mdl-19534727

ABSTRACT

Nitro-fatty acid products of oxidative inflammatory reactions mediate anti-inflammatory cell signalling responses. LNO2 (nitrolinoleic acid) induces expression of HO-1 (haem oxygenase-1), an enzyme that catabolizes haem into products exhibiting potent anti-inflammatory properties. In the present manuscript, the molecular mechanisms underlying HO-1 induction by LNO2 were examined in HAEC (human aortic endothelial cells), HEK-293 (human embryonic kidney 293) cells, and in transcription factor-deficient MEF (mouse embryonic fibroblasts). LNO2 induced HO-1 expression in Nrf2 [NF-E2 (nuclear factor-erythroid 2)-related factor 2]-deficient MEF and in HEK-293 cells transfected with Nrf2-specific shRNA (small-hairpin RNA), supporting the fact that LNO2-mediated HO-1 induction can be regulated by Nrf2-independent mechanisms. LNO2 activated expression of a -4.5 kb human HO-1 promoter construct, whereas a -4.0 kb construct with deletion of 500 bp from the 5' region was unresponsive. Site-directed mutagenesis of a CRE (cAMP-response element) or of a downstream NF-E2/AP-1 (activating protein-1) element, individually, within this 500 bp region modestly reduced activation of the HO-1 promoter by LNO2. Mutations of both the CRE and the NF-E2/AP-1 site also attenuated LNO2-mediated HO-1 promoter expression, whereas the addition of a third mutation in the proximal E-box sequence completely abolished LNO2-induced HO-1 expression. Chromatin immunoprecipitation assays confirmed CREB (CRE-binding protein)-1 binding to the CRE (located at -4.0 kb) and E-box regions (located at -44 bp) of the human HO-1 promoter. A 3C (Chromosome Conformation Capture) assay of intact cells showed LNO2-induced interactions between the CRE- and E-box- containing regions. These observations indicate that regulation of human HO-1 expression by LNO2 requires synergy between CRE, AP-1 and E-box sequences and involves the participation of CREB-1.


Subject(s)
Cyclic AMP/physiology , E-Box Elements/physiology , Heme Oxygenase-1/biosynthesis , Linoleic Acids/metabolism , Nitro Compounds/metabolism , Transcription Factor AP-1/physiology , Animals , Cell Line , Cells, Cultured , Enzyme Induction/drug effects , Enzyme Induction/physiology , Humans , Linoleic Acids/pharmacology , Mice , Nitro Compounds/pharmacology , Protein Binding/drug effects , Protein Binding/physiology
4.
J Exp Med ; 204(3): 605-18, 2007 Mar 19.
Article in English | MEDLINE | ID: mdl-17339405

ABSTRACT

Stromal cell-derived factor 1 (SDF-1) plays a major role in the migration, recruitment, and retention of endothelial progenitor cells to sites of ischemic injury and contributes to neovascularization. We provide direct evidence demonstrating an important role for heme oxygenase 1 (HO-1) in mediating the proangiogenic effects of SDF-1. Nanomolar concentrations of SDF-1 induced HO-1 in endothelial cells through a protein kinase C zeta-dependent and vascular endothelial growth factor-independent mechanism. SDF-1-induced endothelial tube formation and migration was impaired in HO-1-deficient cells. Aortic rings from HO-1(-/-) mice were unable to form capillary sprouts in response to SDF-1, a defect reversed by CO, a byproduct of the HO-1 reaction. Phosphorylation of vasodilator-stimulated phosphoprotein was impaired in HO-1(-/-) cells, an event that was restored by CO. The functional significance of HO-1 in the proangiogenic effects of SDF-1 was confirmed in Matrigel plug, wound healing, and retinal ischemia models in vivo. The absence of HO-1 was associated with impaired wound healing. Intravitreal adoptive transfer of HO-1-deficient endothelial precursors showed defective homing and reendothelialization of the retinal vasculature compared with HO-1 wild-type cells following ischemia. These findings demonstrate a mechanistic role for HO-1 in SDF-1-mediated angiogenesis and provide new avenues for therapeutic approaches in vascular repair.


Subject(s)
Chemokines, CXC/physiology , Heme Oxygenase-1/physiology , Neovascularization, Physiologic , Animals , Cells, Cultured , Chemokine CXCL12 , Endothelial Cells/enzymology , Endothelial Cells/physiology , Endothelium, Vascular/cytology , Endothelium, Vascular/enzymology , Endothelium, Vascular/physiology , Heme Oxygenase-1/deficiency , Heme Oxygenase-1/genetics , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Stromal Cells/enzymology , Wound Healing/genetics , Wound Healing/physiology
5.
J Biol Chem ; 282(9): 6875-86, 2007 Mar 02.
Article in English | MEDLINE | ID: mdl-17204476

ABSTRACT

Heme oxygenase-1 is a highly inducible gene, the product of which catalyzes breakdown of the prooxidant heme. The purpose of this study was to investigate the regulation of the human heme oxygenase-1 gene in renal epithelial cells. DNase I hyper-sensitivity studies identified three distal sites (HS-2, -3, and -4) corresponding to approximately -4.0, -7.2, and -9.2 kb, respectively, of the heme oxygenase-1 promoter in addition to one proximal region, HS-1, which we have shown previously to be an E box. In vivo dimethyl sulfate footprinting of the HS-2 region revealed six individual protected guanines. Two mutations within HS-2 combined with a third mutation of the proximal E box abolished hemin- and cadmium-driven heme oxygenase-1 promoter activation, suggesting that these three sites synergized for maximal heme oxygenase-1 induction. Jun proteins bound to the antioxidant response element in the HS-2 region in vitro and associated with the heme oxygenase-1 promoter in vivo. JunB and JunD contribute opposing effects; JunB activated whereas JunD repressed heme oxygenase-1 expression in human renal epithelial cells, results that were corroborated in junB(-)(/)(-) and junD(-)(/)(-) cells. We propose that heme oxygenase-1 induction is controlled by a dynamic interplay of regulatory proteins, and we provide new insights into the molecular control of the human heme oxygenase-1 gene.


Subject(s)
Gene Expression Regulation, Enzymologic , Heme Oxygenase-1/genetics , Kidney/enzymology , Proto-Oncogene Proteins c-jun/physiology , Animals , Binding Sites , Cell Line , E-Box Elements , Epithelial Cells/enzymology , Epithelial Cells/metabolism , Humans , Kidney/cytology , Mice , Mice, Knockout , Promoter Regions, Genetic
6.
Biochem J ; 383(Pt 2): 209-18, 2004 Oct 15.
Article in English | MEDLINE | ID: mdl-15242350

ABSTRACT

The human HO-1 (haem oxygenase-1) gene encodes a microsomal enzyme responsible for the breakdown of haem, and is also cytoprotective in response to various cellular insults. HO-1 transcription is induced by a vast array of compounds including, but certainly not limited to, haem and heavy metals such as cadmium. In the present study, we show that upstream stimulatory factors, USF1 and USF2, ubiquitous proteins belonging to the basic helix-loop-helix-leucine zipper family of transcription factors, constitutively bind to the class B E-box located in the proximal promoter of the human HO-1 gene and are responsible for the enhancement of HO-1 gene transcription in human renal proximal tubular epithelial cells. Dimethylsulphate in vivo footprinting studies have identified three protected guanine residues in the E-box of the HO-1 proximal promoter. One of these guanine contact points is essential for USF binding, and when mutated mimics a deletion mutation of the entire E-box palindrome sequence encompassing all three guanine contact points. Binding of USF1 and USF2 to the HO-1 E-box was confirmed by chromatin immunoprecipitation and gel-shift assays. Furthermore, we show that overexpression of USF1 or USF2 enhances the basal expression of HO-1 and that expression of a USF dominant negative form reduces its expression. These results demonstrate for the first time that USF proteins bind to the human HO-1 promoter in vivo and are required for high-level expression of HO-1 by haem and cadmium in human renal epithelial cells.


Subject(s)
DNA-Binding Proteins/metabolism , Gene Expression Regulation , Heme Oxygenase (Decyclizing)/genetics , Promoter Regions, Genetic/genetics , Response Elements/genetics , Transcription Factors/metabolism , Transcription, Genetic/genetics , Animals , Base Sequence , Binding Sites , Cadmium/pharmacology , Cell Line , Chromatin Immunoprecipitation , DNA/genetics , DNA/metabolism , DNA Footprinting , DNA-Binding Proteins/genetics , Electrophoretic Mobility Shift Assay , Epithelial Cells , Genes, Dominant/genetics , Guanine/metabolism , Heme/pharmacology , Heme Oxygenase-1 , Humans , Kidney , Membrane Proteins , Protein Binding , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sulfuric Acid Esters/pharmacology , Transcription Factors/genetics , Upstream Stimulatory Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...